相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Neutralization of Variant Under Investigation B.1.617.1 With Sera of BBV152 Vaccinees
Pragya D. Yadav et al.
CLINICAL INFECTIOUS DISEASES (2022)
Recognition of the SARS-CoV-2 receptor binding domain by neutralizing antibodies
Meng Yuan et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2021)
Complete Mapping of Mutations to the SARS-CoV-2 Spike Receptor-Binding Domain that Escape Antibody Recognition
Allison J. Greaney et al.
CELL HOST & MICROBE (2021)
Rational development of a human antibody cocktail that deploys multiple functions to confer Pan-SARS-CoVs protection
Hangping Yao et al.
CELL RESEARCH (2021)
Antibody neutralization of SARS-CoV-2 through ACE2 receptor mimicry
Jiwan Ge et al.
NATURE COMMUNICATIONS (2021)
Enhancement versus neutralization by SARS-CoV-2 antibodies from a convalescent donor associates with distinct epitopes on the RBD
Yunjiao Zhou et al.
CELL REPORTS (2021)
The antigenic anatomy of SARS-CoV-2 receptor binding domain
Wanwisa Dejnirattisai et al.
CELL (2021)
Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity
Wilfredo F. Garcia-Beltran et al.
CELL (2021)
Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera
Daming Zhou et al.
CELL (2021)
SARS-CoV-2 variant B.1.1.7 is susceptible to neutralizing antibodies elicited by ancestral spike vaccines
Xiaoying Shen et al.
CELL HOST & MICROBE (2021)
Comprehensive mapping of mutations in the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human plasma antibodies
Allison J. Greaney et al.
CELL HOST & MICROBE (2021)
Emerging SARS-CoV-2 variants reduce neutralization sensitivity to convalescent sera and monoclonal antibodies
Jie Hu et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2021)
Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies
Dami A. Collier et al.
NATURE (2021)
Detection of a SARS-CoV-2 variant of concern in South Africa
Houriiyah Tegally et al.
NATURE (2021)
Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7
Pengfei Wang et al.
NATURE (2021)
mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants
Zijun Wang et al.
NATURE (2021)
Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies
Rita E. Chen et al.
NATURE MEDICINE (2021)
SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma
Constantinos Kurt Wibmer et al.
NATURE MEDICINE (2021)
Neutralization of SARS-CoV-2 spike 69/70 deletion, E484K and N501Y variants by BNT162b2 vaccine-elicited sera
Xuping Xie et al.
NATURE MEDICINE (2021)
Serum Neutralizing Activity Elicited by mRNA-1273 Vaccine
Kai Wu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Neutralizing Activity of BNT162b2-Elicited Serum
Yang Liu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Multi-clonal SARS-CoV-2 neutralization by antibodies isolated from severe COVID-19 convalescent donors
Michael Mor et al.
PLOS PATHOGENS (2021)
SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies
Markus Hoffmann et al.
CELL (2021)
SARS-CoV-2 evolution in an immunocompromised host reveals shared neutralization escape mechanisms
Sarah A. Clark et al.
CELL (2021)
Antibody evasion by the P.1 strain of SARS-CoV-2
Wanwisa Dejnirattisai et al.
CELL (2021)
Infection- and vaccine-induced antibody binding and neutralization of the B.1.351 SARS-CoV-2 variant
Venkata Viswanadh Edara et al.
CELL HOST & MICROBE (2021)
A combination of cross-neutralizing antibodies synergizes to prevent SARS-CoV-2 and SARS-CoV pseudovirus infection
Hejun Liu et al.
CELL HOST & MICROBE (2021)
Increased resistance of SARS-CoV-2 variant P.1 to antibody neutralization
Pengfei Wang et al.
CELL HOST & MICROBE (2021)
Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial
Katherine R. W. Emary et al.
LANCET (2021)
Escape of SARS-CoV-2 501Y.V2 from neutralization by convalescent plasma
Sandile Cele et al.
NATURE (2021)
Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies
Delphine Planas et al.
NATURE MEDICINE (2021)
mRNA vaccination boosts cross-variant neutralizing antibodies elicited by SARS-CoV-2 infection
Leonidas Stamatatos et al.
SCIENCE (2021)
Modular basis for potent SARS-CoV-2 neutralization by a prevalent VH1-2-derived antibody class
Micah Rapp et al.
CELL REPORTS (2021)
Cryo-electron microscopy structures of the N501Y SARS-CoV-2 spike protein in complex with ACE2 and 2 potent neutralizing antibodies
Xing Zhu et al.
PLOS BIOLOGY (2021)
A Rapid and Efficient Screening System for Neutralizing Antibodies and Its Application for SARS-CoV-2
Xiaojian Han et al.
FRONTIERS IN IMMUNOLOGY (2021)
In vitro and in vivo functions of SARS-CoV-2 infection-enhancing and neutralizing antibodies
Dapeng Li et al.
CELL (2021)
Analysis of SARS-CoV-2 variant mutations reveals neutralization escape mechanisms and the ability to use ACE2 receptors from additional species
Ruoke Wang et al.
IMMUNITY (2021)
Acquisition of the L452R Mutation in the ACE2-Binding Interface of Spike Protein Triggers Recent Massive Expansion of SARS-CoV-2 Variants
Veronika Tchesnokova et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2021)
SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape
Tyler N. Starr et al.
NATURE (2021)
Ultrapotent antibodies against diverse and highly transmissible SARS-CoV-2 variants
Lingshu Wang et al.
SCIENCE (2021)
Structural basis for accommodation of emerging B.1.351 and B.1.1.7 variants by two potent SARS-CoV-2 neutralizing antibodies
Gabriele Cerutti et al.
STRUCTURE (2021)
Cross-Reactive SARS-CoV-2 Neutralizing Antibodies From Deep Mining of Early Patient Responses
Georgia Bullen et al.
FRONTIERS IN IMMUNOLOGY (2021)
Cross-reactive coronavirus antibodies with diverse epitope specificities and Fc effector functions
Andrea R. Shiakolas et al.
CELL REPORTS MEDICINE (2021)
Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
Alexandra C. Walls et al.
CELL (2020)
A noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2
Yan Wu et al.
SCIENCE (2020)
A highly conserved cryptic epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoV
Meng Yuan et al.
SCIENCE (2020)
Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period
Stephen M. Kissler et al.
SCIENCE (2020)
A human neutralizing antibody targets the receptor-binding site of SARS-CoV-2
Rui Shi et al.
NATURE (2020)
Human neutralizing antibodies elicited by SARS-CoV-2 infection
Bin Ju et al.
NATURE (2020)
Cross-neutralization ofSARS-CoV-2 by a human monoclonal SARS-CoV antibody
Dora Pinto et al.
NATURE (2020)
Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor
Jun Lan et al.
NATURE (2020)
Deep Mutational Scanning of SARS-CoV-2 Receptor Binding Domain Reveals Constraints on Folding and ACE2 Binding
Tyler N. Starr et al.
CELL (2020)
Longitudinal Isolation of Potent Near-Germline SARS-CoV-2-Neutralizing Antibodies from COVID-19 Patients
Christoph Kreer et al.
CELL (2020)
Structures of Human Antibodies Bound to SARS-CoV-2 Spike Reveal Common Epitopes and Recurrent Features of Antibodies
Christopher O. Barnes et al.
CELL (2020)
Potent Neutralizing Antibodies against SARS-CoV-2 Identified by High-Throughput Single-Cell Sequencing of Convalescent Patients' B Cells
Yunlong Cao et al.
CELL (2020)
Analysis of a SARS-CoV-2-Infected Individual Reveals Development of Potent Neutralizing Antibodies with Limited Somatic Mutation
Emilie Seydoux et al.
IMMUNITY (2020)
CoV-AbDab: the Coronavirus Antibody Database
Matthew I J Raybould et al.
BIOINFORMATICS (2020)
A Therapeutic Non-self-reactive SARS-CoV-2 Antibody Protects from Lung Pathology in a COVID-19 Hamster Model
Jakob Kreye et al.
CELL (2020)
Structurally Resolved SARS-CoV-2 Antibody Shows High Efficacy in Severely Infected Hamsters and Provides a Potent Cocktail Pairing Strategy
Shuo Du et al.
CELL (2020)
Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology
Luca Piccoli et al.
CELL (2020)
Convergent antibody responses to SARS-CoV-2 in convalescent individuals
Davide F. Robbiani et al.
NATURE (2020)
Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike
Lihong Liu et al.
NATURE (2020)
Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein
Seth J. Zost et al.
NATURE MEDICINE (2020)
A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2
Xiangyang Chi et al.
SCIENCE (2020)
Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model
Thomas F. Rogers et al.
SCIENCE (2020)
Structure-based design of prefusion-stabilized SARS-CoV-2 spikes
Ching-Lin Hsieh et al.
SCIENCE (2020)
Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail
Johanna Hansen et al.
SCIENCE (2020)
Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability
Philip J. M. Brouwer et al.
SCIENCE (2020)
Structural basis of a shared antibody response to SARS-CoV-2
Meng Yuan et al.
SCIENCE (2020)
Human-IgG-Neutralizing Monoclonal Antibodies Block the SARS-CoV-2 Infection
Jinkai Wan et al.
CELL REPORTS (2020)
SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies
Christopher O. Barnes et al.
NATURE (2020)
Structural analysis of full-length SARS-CoV-2 spike protein from an advanced vaccine candidate
Sandhya Bangaru et al.
SCIENCE (2020)
Ultrapotent human antibodies protect against SARS-CoV-2 challenge via multiple mechanisms
M. Alejandra Tortorici et al.
SCIENCE (2020)
A panel of human neutralizing mAbs targeting SARS-CoV-2 spike at multiple epitopes
Tal Noy-Porat et al.
NATURE COMMUNICATIONS (2020)
An Alternative Binding Mode of IGHV3-53 Antibodies to the SARS-CoV-2 Receptor Binding Domain
Nicholas C. Wu et al.
CELL REPORTS (2020)
Cross-Neutralization of a SARS-CoV-2 Antibody to a Functionally Conserved Site Is Mediated by Avidity
Hejun Liu et al.
IMMUNITY (2020)
Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host
Bina Choi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants
Yiska Weisblum et al.
ELIFE (2020)
Structural basis for potent neutralization of SARS-CoV-2 and role of antibody affinity maturation
Nicholas K. Hurlburt et al.
NATURE COMMUNICATIONS (2020)
Repertoire Builder: high-throughput structural modeling of B and T cell receptors
Dimitri Schritt et al.
MOLECULAR SYSTEMS DESIGN & ENGINEERING (2019)
New tools for automated high-resolution cryo-EM structure determination in RELION-3
Jasenko Zivanov et al.
ELIFE (2018)
GISAID: Global initiative on sharing all influenza data - from vision to reality
Yuelong Shu et al.
EUROSURVEILLANCE (2017)
Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen
Jesper Pallesen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
A Highly Conserved Neutralizing Epitope on Group 2 Influenza A Viruses
Damian C. Ekiert et al.
SCIENCE (2011)
Features and development of Coot
P. Emsley et al.
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY (2010)
PHENIX: a comprehensive Python-based system for macromolecular structure solution
Paul D. Adams et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2010)
Individual Variation in the Germline Ig Gene Repertoire Inferred from Variable Region Gene Rearrangements
Scott D. Boyd et al.
JOURNAL OF IMMUNOLOGY (2010)
Appion: An integrated, database-driven pipeline to facilitate EM image processing
Gabriel C. Lander et al.
JOURNAL OF STRUCTURAL BIOLOGY (2009)
DoG Picker and TiltPicker: Software tools to facilitate particle selection in single particle electron microscopy
N. R. Voss et al.
JOURNAL OF STRUCTURAL BIOLOGY (2009)
The challenges of eliciting neutralizing antibodies to HIV-1 and to influenza virus
Gunilla B. Karlsson Hedestam et al.
NATURE REVIEWS MICROBIOLOGY (2008)
Inference of macromolecular assemblies from crystalline state
Evgeny Krissinel et al.
JOURNAL OF MOLECULAR BIOLOGY (2007)
Phaser crystallographic software
Airlie J. McCoy et al.
JOURNAL OF APPLIED CRYSTALLOGRAPHY (2007)
Automated molecular microscopy: The new Leginon system
C Suloway et al.
JOURNAL OF STRUCTURAL BIOLOGY (2005)
UCSF chimera - A visualization system for exploratory research and analysis
EF Pettersen et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2004)